Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors.

Stéphane Berghmans1, Ryan D Murphey, Erno Wienholds

  • 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Proceedings of the National Academy of Sciences of the United States of America
|January 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reactivation of a TAL1 progenitor cell enhancer region by non-coding somatic variants in T-lineage acute lymphoblastic leukemia.

bioRxiv : the preprint server for biology·2026
Same author

Transcription factor cooperativity at a GATA3 tandem DNA sequence determines oncogenic enhancer-mediated activation.

Cell reports·2026
Same author

Multitargeted Reduction of Inflammation and Atherosclerosis in <i>Tet2</i> -deficient CHIP via XPO1 Inhibition and Atf3 restoration.

bioRxiv : the preprint server for biology·2025
Same author

KAT6A/B inhibition synergizes with retinoic acid and enhances the efficacy of GD2-targeted immunotherapy in neuroblastoma.

bioRxiv : the preprint server for biology·2025
Same author

Transcription factor cooperativity at a GATA3 tandem DNA sequence determines oncogenic enhancer-mediated activation.

Cell reports·2025
Same author

Accurate Measurement of Cell Number-Normalized Differential Gene Expression in Cells Treated With Retinoic Acid.

Bio-protocol·2024

Researchers developed zebrafish models with tp53 mutations, similar to human cancers. These models exhibit impaired apoptosis and cell-cycle control, leading to tumor development, offering new avenues for cancer research.

Area of Science:

  • Genetics
  • Cancer Biology
  • Developmental Biology

Background:

  • TP53 is a crucial tumor suppressor gene, frequently mutated in human cancers.
  • Understanding TP53's role in cancer requires effective model systems.
  • Zebrafish offer a powerful vertebrate model for genetic studies.

Purpose of the Study:

  • To create and characterize zebrafish models with tp53 mutations.
  • To investigate the functional consequences of tp53 mutations on apoptosis and cell-cycle control.
  • To establish a platform for identifying modifiers of tp53-related cancer pathways.

Main Methods:

  • Target-selected mutagenesis in zebrafish to generate tp53 mutations.
  • Analysis of homozygous mutant zebrafish lines (tp53(N168K) and tp53(M214K)).

Related Experiment Videos

  • Assessment of radiation-induced apoptosis, cell-cycle arrest, and tumor development.

    • Main Results:

    • Identified viable zebrafish lines with tp53 mutations mimicking human cancer mutations.
    • tp53(M214K) mutants showed impaired radiation-induced apoptosis and G1/S cell-cycle arrest.
    • 28% of tp53(M214K) mutants developed malignant peripheral nerve sheath tumors.

    Conclusions:

    • Zebrafish models with tp53 mutations accurately recapitulate aspects of human cancer.
    • These models are valuable for studying malignant peripheral nerve sheath tumors.
    • The mutant lines serve as a platform for discovering therapeutic targets in tp53-related cancers.